111 Operating Margin 2018-2024 | YI

Current and historical operating margin for 111 (YI) over the last 10 years. The current operating profit margin for 111 as of June 30, 2024 is -2.27%.
111 Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-06-30 $2.05B $-0.04B -1.91%
2024-03-31 $2.06B $-0.05B -2.19%
2023-12-31 $2.11B $-0.05B -2.33%
2023-09-30 $2.09B $-0.03B -1.63%
2023-06-30 $2.05B $-0.03B -1.66%
2023-03-31 $2.03B $-0.04B -1.97%
2022-12-31 $1.96B $-0.05B -2.71%
2022-09-30 $1.96B $-0.06B -2.91%
2022-06-30 $2.01B $-0.07B -3.64%
2022-03-31 $2.02B $-0.09B -4.45%
2021-12-31 $1.95B $-0.10B -5.13%
2021-09-30 $1.84B $-0.11B -5.82%
2021-06-30 $1.67B $-0.10B -5.87%
2021-03-31 $1.43B $-0.08B -5.73%
2020-12-31 $1.26B $-0.07B -5.72%
2020-09-30 $0.99B $-0.07B -7.14%
2020-06-30 $0.80B $-0.07B -8.74%
2020-03-31 $0.69B $-0.07B -10.39%
2019-12-31 $0.57B $-0.07B -12.68%
2019-09-30 $0.45B $-0.07B -14.99%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.052B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $9.226B 0.00
Inspire Medical Systems (INSP) United States $5.656B 176.38
Hims & Hers Health (HIMS) United States $5.534B 140.72
Enovis (ENOV) United States $2.608B 17.68
Privia Health (PRVA) United States $2.587B 215.60
IRhythm Technologies (IRTC) United States $2.316B 0.00
Azenta (AZTA) United States $2.209B 110.15
Omnicell (OMCL) United States $2.116B 69.23
10x Genomics (TXG) United States $1.732B 0.00
Clover Health Investments (CLOV) United States $1.689B 0.00
Schrodinger (SDGR) United States $1.518B 0.00
Phreesia (PHR) United States $1.148B 0.00
Butterfly Network (BFLY) United States $0.690B 0.00
Standard BioTools (LAB) United States $0.596B 0.00
Talkspace (TALK) United States $0.583B 0.00
Fulgent Genetics (FLGT) United States $0.547B 0.00
Definitive Healthcare (DH) United States $0.505B 87.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.268B 0.00
TruBridge (TBRG) United States $0.247B 71.91
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
American Well (AMWL) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.112B 0.00
P3 Health Partners (PIII) United States $0.076B 0.00
HeartBeam (BEAT) United States $0.074B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.044B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zepp Health (ZEPP) China $0.037B 0.00
Movano (MOVE) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
MSP Recovery (LIFW) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00